ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ARWR fundamentals
During Q1 2026, Arrowhead Pharmaceuticals (ARWR) reported revenue of 264.03M, a YoY change of 10461.32%. Net income was 28.24M, a YoY change of 116.12%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | TTM |
|---|
Start Date | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | -- |
Revenue | 43.75K -- | 39.58K -68.01% | 31.25K -28.57% | 4.37M +9878.28% | 8.99M +20439.27% | 9.34M +23502.30% | 8.71M +27784.12% | 3.51M -19.60% | 650.13K -92.77% | 727.38K -92.21% | 11.26M +29.16% | 34.66M +887.45% | 48.15M +7306.00% | 42.70M +5769.96% | 43.29M +284.66% | 29.45M -15.01% | 23.53M -51.13% | 27.38M -35.88% | 7.63M -82.37% | 21.30M -27.68% | 32.81M +39.45% | 45.89M +67.63% | 38.28M +401.55% | 27.44M +28.80% | 151.81M +362.66% | 32.41M -29.37% | 31.57M -17.52% | 62.55M +127.95% | 146.27M -3.65% | 15.82M -51.18% | 16.10M -49.02% | 3.55M -94.32% | -- -- | -- -- | -- -- | 2.50M -29.60% | 542.71M -- | 27.77M -- | 256.47M -- | 264.03M +10461.32% | 1.09B -- |
Sales and Services Revenue | 43.75K -- | 39.58K -68.01% | 31.25K -28.57% | 4.37M +9878.28% | 8.99M +20439.27% | 9.34M +23502.30% | 8.71M +27784.12% | 3.51M -19.60% | 650.13K -92.77% | 727.38K -92.21% | 11.26M +29.16% | 34.66M +887.45% | 48.15M +7306.00% | 42.70M +5769.96% | 43.29M +284.66% | 29.45M -15.01% | 23.53M -51.13% | 27.38M -35.88% | 7.63M -82.37% | 21.30M -27.68% | 32.81M +39.45% | 45.89M +67.63% | 38.28M +401.55% | 27.44M +28.80% | 151.81M +362.66% | 32.41M -29.37% | 31.57M -17.52% | 62.55M +127.95% | 146.27M -3.65% | 15.82M -51.18% | 16.10M -49.02% | 3.55M -94.32% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 2.50M -29.60% | 542.71M -- | 27.77M -- | 256.47M -- | 264.03M +10461.32% | 1.09B -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 43.75K -- | 39.58K -68.01% | -127.08K -390.48% | 4.37M +9878.28% | 8.99M +20439.27% | 9.34M +23502.30% | -22.69M -17757.56% | 3.51M -19.60% | 650.13K -92.77% | 727.38K -92.21% | -4.89M +78.46% | 34.66M +887.45% | 48.15M +7306.00% | 42.70M +5769.96% | -125.50M -2467.93% | 29.45M -15.01% | 23.53M -51.13% | 27.38M -35.88% | -80.36M +35.97% | 21.30M -27.68% | 32.81M +39.45% | 45.89M +67.63% | -100.00M -24.45% | 27.44M +28.80% | 151.81M +362.66% | 32.41M -29.37% | -211.66M -111.65% | 62.55M +127.95% | 146.27M -3.65% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | 5.86M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 21.31M -28.20% | 19.38M +20.25% | 27.69M +9.56% | 19.27M -0.61% | 15.12M -29.06% | 15.06M -22.31% | 18.96M -31.51% | 17.32M -10.09% | 15.68M +3.76% | 16.65M +10.56% | 22.42M +18.25% | 23.71M +36.88% | 26.14M +66.65% | 24.10M +44.78% | 33.65M +50.08% | 34.31M +44.69% | 45.77M +75.11% | 43.32M +79.75% | 57.75M +71.60% | 45.36M +32.21% | 61.04M +33.37% | 77.76M +79.49% | 103.17M +78.64% | 90.76M +100.10% | 110.25M +80.61% | 105.32M +35.45% | 115.41M +11.86% | 104.68M +15.34% | 98.10M -11.02% | 118.53M +12.54% | 124.43M +7.82% | 140.10M +33.83% | 126.19M +28.63% | 176.14M +48.61% | 162.20M +30.36% | 163.91M +17.00% | 161.51M +27.99% | 193.32M +9.75% | 212.37M +30.93% | 223.22M +36.19% | 790.41M -- |
Selling, General and Administrative Expenses | 11.29M +43.01% | 9.96M +15.43% | -6.70M -151.54% | 9.74M +7.67% | 3.68M -67.42% | 3.92M -60.63% | 5.42M +180.97% | 4.40M -54.79% | 3.68M +0.12% | 4.59M +17.21% | 6.43M +18.58% | 6.14M +39.43% | 5.34M +45.01% | 4.81M +4.67% | 10.27M +59.69% | 10.93M +78.09% | 16.33M +205.79% | 10.75M +123.51% | 14.27M +38.94% | 8.80M -19.50% | 16.35M +0.12% | 18.43M +71.50% | 37.40M +162.14% | 25.00M +183.97% | 34.27M +109.64% | 33.14M +79.78% | 32.03M -14.36% | 20.98M -16.04% | 23.22M -32.24% | 23.77M -28.27% | 24.57M -23.28% | 23.61M +12.49% | 25.07M +7.96% | 23.71M -0.26% | 26.38M +7.35% | 26.91M +14.00% | 28.41M +13.31% | 30.95M +30.53% | 37.68M +42.85% | 46.02M +71.02% | 143.05M -- |
General and Administrative Expenses | -- -- | -- -- | 23.59M -- | -- -- | -- -- | -- -- | 17.50M -25.83% | -- -- | -- -- | -- -- | 19.11M +9.21% | -- -- | -- -- | -- -- | 26.56M +38.96% | -- -- | -- -- | -- -- | 52.28M +96.85% | -- -- | -- -- | -- -- | 80.98M +54.91% | -- -- | -- -- | -- -- | 124.43M +53.65% | -- -- | -- -- | 23.77M -- | 24.57M -80.25% | 23.61M -- | 25.07M -- | 23.71M -0.26% | 26.38M +7.35% | 26.91M +14.00% | 28.41M +13.31% | 30.95M +30.53% | 37.68M +42.85% | 46.02M +71.02% | 143.05M -- |
Research and Development Expenses | 10.02M -54.00% | 9.42M +25.80% | 32.33M +211.23% | 9.53M -7.85% | 11.44M +14.14% | 11.14M +18.18% | 13.54M -58.12% | 12.92M +35.61% | 12.00M +4.93% | 12.05M +8.22% | 15.99M +18.11% | 17.57M +36.01% | 20.80M +73.29% | 19.29M +60.06% | 23.39M +46.22% | 23.37M +33.02% | 29.44M +41.56% | 32.57M +68.84% | 43.48M +85.94% | 36.55M +56.39% | 44.70M +51.81% | 59.33M +82.13% | 65.77M +51.24% | 65.77M +79.91% | 75.98M +70.00% | 72.18M +21.67% | 83.38M +26.78% | 83.69M +27.26% | 74.88M -1.45% | 94.76M +31.28% | 99.86M +19.76% | 116.49M +39.19% | 101.12M +35.04% | 152.43M +60.87% | 135.83M +36.02% | 137.00M +17.61% | 133.10M +31.63% | 162.37M +6.52% | 174.69M +28.61% | 177.20M +29.34% | 647.36M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | 2.05M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -21.26M +28.24% | -19.34M -20.93% | -21.80M +13.61% | -14.90M +22.95% | -6.13M +71.17% | -5.71M +70.46% | -10.25M +52.97% | -13.81M +7.30% | -15.03M -145.27% | -15.92M -178.60% | -11.17M -8.96% | 10.95M +179.24% | 22.01M +246.41% | 18.60M +216.81% | 9.64M +186.30% | -4.85M -144.34% | -22.24M -201.04% | -15.95M -185.75% | -50.12M -619.99% | -24.05M -395.65% | -28.23M -26.94% | -31.87M -99.85% | -64.88M -29.46% | -63.32M -163.25% | 41.55M +247.18% | -72.91M -128.78% | -83.83M -29.20% | -42.13M +33.46% | 48.16M +15.91% | -102.70M -40.86% | -108.33M -29.23% | -136.54M -224.07% | -126.19M -362.00% | -176.14M -71.51% | -162.20M -49.73% | -161.41M -18.21% | 381.20M +402.08% | -165.55M +6.01% | 44.11M +127.19% | 40.81M +125.28% | 300.57M -- |
Non-Operating Income (Loss) | 449.00K -52.68% | -79.26K -237.47% | -424.47K -186.79% | 2.82M +3563.71% | 87.08K -80.60% | 194.42K +345.31% | -479.27K -12.91% | 614.47K -78.18% | 149.75K +71.96% | 313.70K +61.35% | 410.24K +185.60% | 1.09M +77.57% | 1.89M +1159.64% | 1.74M +454.65% | 2.24M +446.18% | 2.18M +99.80% | 2.40M +27.45% | 2.33M +34.20% | 1.69M -24.66% | 3.32M +52.39% | 1.41M -41.18% | 1.94M -16.75% | 1.51M -10.49% | 449.00K -86.48% | 2.81M +98.94% | 863.00K -55.61% | 1.67M +10.72% | 340.00K -24.28% | -489.00K -117.38% | -680.00K -178.79% | -660.00K -139.45% | -2.14M -730.59% | -805.00K -64.62% | 2.16M +418.24% | -10.60M -1505.30% | -13.70M -539.13% | -11.59M -1339.25% | -13.54M -725.65% | -7.99M +24.63% | -12.54M +8.50% | -45.65M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -301.02K -- | -- -- | -- -- | -- -- | 890.36K +395.78% | -- -- | -- -- | -- -- | 432.14K -51.46% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 369.94K -50.72% | -113.36K -8.26% | -175.70K -149.10% | 2.79M +11962.91% | -21.66K -105.85% | 63.06K +155.63% | -1.52M -764.83% | 450.74K -83.85% | -18.60K +14.13% | -- -- | -424.65K +72.05% | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -583.00K -- | 1.15M -- | -110.00K -- | 664.00K -- | 363.00K +162.26% | -707.00K -161.32% | 1.76M +1699.09% | -377.00K -156.78% | 90.00K -75.21% | 507.00K +171.71% | 8.00K -99.55% | 306.00K +181.17% | 717.00K +696.67% | 421.00K -16.96% | 189.00K +2262.50% | 760.00K +148.37% | -3.12M -534.87% | 341.00K -19.00% | 438.00K +131.75% | -176.00K -123.16% | 4.66M +249.33% | 277.00K -18.77% | 5.20M -- |
Net Interest Expense | -79.06K +60.09% | -34.10K +79.00% | -52.25K +60.19% | -25.15K +74.95% | -108.74K -37.55% | -131.36K -285.18% | -149.88K -186.84% | -163.73K -551.07% | -168.35K -54.81% | -313.70K -138.81% | -402.75K -168.72% | -1.09M -566.40% | -1.89M -1020.48% | -1.74M -454.65% | -2.24M -456.34% | -2.18M -99.80% | -2.40M -27.45% | -2.33M -34.20% | -2.27M -1.35% | -2.17M +0.50% | -1.52M +36.61% | -1.28M +45.18% | -1.15M +49.45% | -1.16M +46.70% | -1.05M +30.84% | -1.24M +3.13% | -1.58M -37.89% | 167.00K +114.45% | 497.00K +147.15% | 986.00K +179.52% | 1.38M +186.99% | 2.56M +1435.93% | 994.00K +100.00% | -1.40M -242.39% | 7.48M +442.99% | 14.04M +447.52% | 12.02M +1109.66% | 13.36M +1051.78% | 12.64M +69.07% | 12.81M -8.75% | 50.84M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | 2.85M -- | 5.06M -- | 5.16M -- | 5.26M -- | 5.37M +88.38% | 7.24M +43.25% | 5.09M -1.24% | 14.65M +178.35% | 21.65M +303.32% | 21.64M +198.72% | 24.38M +378.64% | 21.69M +48.11% | 22.50M +3.97% | 90.22M -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.40M -- | 2.33M -- | 2.27M -- | 2.17M -- | 1.52M -36.61% | 1.28M -45.18% | 1.15M -49.45% | -- -- | 1.05M -30.84% | 1.24M -3.13% | 1.58M +37.89% | 2.68M -- | 4.56M +332.64% | 4.17M +236.45% | 3.88M +145.42% | 2.80M +4.47% | 6.25M +37.06% | 6.50M +55.75% | 7.17M +84.56% | 7.60M +171.31% | 9.62M +53.84% | 11.02M +69.58% | 9.05M +26.26% | 9.69M +27.47% | 39.38M -- |
Pretax Income From Continuing Operations | -20.82M +27.43% | -19.42M -21.87% | -22.22M +10.19% | -12.09M +37.26% | -6.04M +70.97% | -5.52M +71.58% | -10.73M +51.71% | -13.20M -9.21% | -14.88M -146.32% | -15.61M -182.73% | -10.76M -0.27% | 12.04M +191.20% | 23.90M +260.55% | 20.34M +230.31% | 11.88M +210.41% | -2.67M -122.21% | -19.84M -183.01% | -13.61M -166.93% | -48.43M -507.70% | -20.73M -675.61% | -26.82M -35.20% | -29.92M -119.85% | -63.37M -30.85% | -62.87M -203.26% | 44.37M +265.43% | -72.05M -140.76% | -82.16M -29.64% | -41.79M +33.53% | 47.68M +7.46% | -103.38M -43.50% | -108.99M -32.66% | -138.69M -231.84% | -127.00M -366.37% | -173.98M -68.28% | -172.80M -58.54% | -175.12M -26.26% | 369.62M +391.05% | -179.09M -2.94% | 36.12M +120.90% | 28.27M +116.14% | 254.92M -- |
Income Tax Expense | -- -- | -- -- | 2.40K -- | -- -- | -- -- | -- -- | 2.40K -- | 0 -- | -- -- | 0 -- | 2.40K -- | -- -- | -- -- | -- -- | 174.00K +7150.00% | -- -- | -- -- | -- -- | 2.00K -98.85% | -- -- | -- -- | 0 -- | 2.00K -- | 0 -- | 0 -- | 0 -- | 3.79M +189150.00% | 17.00K -- | 0 -- | 742.00K -- | 2.02M -46.50% | -3.31M -19588.24% | -- -- | -- -- | 546.00K -73.04% | 103.00K +103.11% | 1.75M -- | -437.00K -- | 20.00M +3563.00% | 29.00K -71.84% | 21.34M -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.00K -- | -- -- | -- -- | -- -- | 3.79M +189150.00% | -- -- | -- -- | -- -- | 2.78M -26.45% | -- -- | -- -- | -- -- | -2.77M -199.39% | -- -- | -- -- | -- -- | 21.42M +874.09% | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- |
Net Income | -20.82M +27.43% | -19.42M -21.87% | -22.22M +10.19% | -12.09M +37.26% | -6.04M +70.97% | -5.52M +71.58% | -10.73M +51.71% | -13.20M -9.21% | -14.88M -146.32% | -15.61M -182.73% | -10.76M -0.27% | 12.04M +191.20% | 23.90M +260.55% | 20.34M +230.31% | 11.71M +208.77% | -2.67M -122.21% | -19.84M -183.01% | -13.61M -166.93% | -48.43M -513.78% | -20.73M -675.61% | -26.82M -35.20% | -29.92M -119.85% | -63.37M -30.85% | -62.87M -203.26% | 44.37M +265.43% | -72.05M -140.76% | -85.94M -35.61% | -41.81M +33.50% | 47.68M +7.46% | -104.13M -44.53% | -111.02M -29.17% | -135.38M -223.78% | -127.00M -366.37% | -173.98M -67.08% | -173.34M -56.14% | -175.22M -29.43% | 367.86M +389.67% | -178.65M -2.69% | 16.12M +109.30% | 28.24M +116.12% | 233.57M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -431.00K -- | -486.00K -- | -999.00K -- | -1.18M -- | -1.34M -209.98% | -2.51M -416.87% | -1.70M -69.77% | -3.18M -170.06% | -2.81M -110.18% | -2.13M +15.09% | -2.58M -52.24% | -3.41M -7.13% | 39.87M +1519.91% | -2.57M -20.44% | 31.31M -- |
Net Income Attributable to Owners of the Company | -20.82M +27.43% | -19.42M -21.87% | -22.22M +10.19% | -12.09M +37.26% | -6.04M +70.97% | -5.52M +71.58% | -10.73M +51.71% | -13.20M -9.21% | -14.88M -146.32% | -15.61M -182.73% | -10.76M -0.27% | 12.04M +191.20% | 23.90M +260.55% | 20.34M +230.31% | 11.71M +208.77% | -2.67M -122.21% | -19.84M -183.01% | -13.61M -166.93% | -48.43M -513.78% | -20.73M -675.61% | -26.82M -35.20% | -29.92M -119.85% | -63.37M -30.85% | -62.87M -203.26% | 44.37M +265.43% | -72.05M -140.76% | -85.51M -34.93% | -41.33M +34.27% | 48.67M +9.71% | -102.95M -42.89% | -109.68M -28.26% | -132.86M -221.51% | -125.30M -357.42% | -170.79M -65.91% | -170.54M -55.49% | -173.09M -30.27% | 370.44M +395.65% | -175.24M -2.60% | -23.75M +86.07% | 30.81M +117.80% | 202.26M -- |
Net Income Attributable to Common Stockholders | -20.82M +27.43% | -19.42M -21.87% | -22.22M +10.19% | -12.09M +37.26% | -6.04M +70.97% | -5.52M +71.58% | -10.73M +51.71% | -13.20M -9.21% | -14.88M -146.32% | -15.61M -182.73% | -10.76M -0.27% | 12.04M +191.20% | 23.90M +260.55% | 20.34M +230.31% | 11.71M +208.77% | -2.67M -122.21% | -19.84M -183.01% | -13.61M -166.93% | -48.43M -513.78% | -20.73M -675.61% | -26.82M -35.20% | -29.92M -119.85% | -63.37M -30.85% | -62.87M -203.26% | 44.37M +265.43% | -72.05M -140.76% | -85.51M -34.93% | -41.33M +34.27% | 48.67M +9.71% | -102.95M -42.89% | -109.68M -28.26% | -132.86M -221.51% | -125.30M -357.42% | -170.79M -65.91% | -170.54M -55.49% | -173.09M -30.27% | 370.44M +395.65% | -175.24M -2.60% | -23.75M +86.07% | 30.81M +117.80% | 202.26M -- |
Other Comprehensive Income | 150.52K +335.32% | -90.63K -4472.40% | 38.16K +154.15% | -192.61K -520.38% | 154.46K +2.62% | 12.31K +113.58% | 51.62K +35.26% | -9.53K +95.05% | 1.56K -98.99% | -28.60K -332.37% | -18.23K -135.31% | -22.18K -132.79% | -28.16K -1904.10% | -31.17K -8.98% | -288.49K -1482.83% | 196.00K +983.68% | -433.00K -1437.53% | 454.00K +1556.44% | 194.00K +167.25% | 180.00K -8.16% | -96.00K +77.83% | -40.00K -108.81% | -131.00K -167.53% | -39.00K -121.67% | 1.00K +101.04% | -33.00K +17.50% | 4.00K +103.05% | -122.00K -212.82% | -74.00K -7500.00% | -79.00K -139.39% | -2.81M -70375.00% | 1.97M +1712.30% | 160.00K +316.22% | 108.00K +236.71% | 5.74M +304.09% | -613.00K -131.16% | 253.00K +58.13% | 967.00K +795.37% | 1.09M -81.07% | 256.00K +141.76% | 2.56M -- |
Total Comprehensive Income | -20.67M +28.12% | -19.51M -22.42% | -22.18M +10.60% | -12.28M +36.11% | -5.89M +71.51% | -5.51M +71.77% | -10.68M +51.86% | -13.21M -7.57% | -14.88M -152.76% | -15.63M -183.88% | -10.78M -0.93% | 12.02M +190.97% | 23.87M +260.38% | 20.30M +229.87% | 11.42M +205.91% | -2.48M -120.62% | -20.27M -184.92% | -13.16M -164.80% | -48.24M -522.53% | -20.55M -729.71% | -26.91M -32.78% | -29.96M -127.74% | -63.51M -31.65% | -62.91M -206.11% | 44.37M +264.85% | -72.08M -140.55% | -85.94M -35.32% | -41.93M +33.35% | 47.60M +7.29% | -104.20M -44.57% | -113.83M -32.45% | -133.41M -218.15% | -126.84M -366.45% | -173.87M -66.85% | -167.61M -47.25% | -175.83M -31.80% | 368.12M +390.23% | -177.69M -2.19% | 17.21M +110.27% | 28.50M +116.21% | 236.14M -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.00M -- | -- -- | -- -- | -- -- | -10.20M -155.00% | -2.13M -- | -- -- | -- -- | 31.75M +411.23% | -2.57M -20.44% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -20.67M +28.12% | -19.51M -22.42% | -22.18M +10.60% | -12.28M +36.11% | -5.89M +71.51% | -5.51M +71.77% | -10.68M +51.86% | -13.21M -7.57% | -14.88M -152.76% | -15.63M -183.88% | -10.78M -0.93% | 12.02M +190.97% | 23.87M +260.38% | 20.30M +229.87% | 11.42M +205.91% | -2.48M -120.62% | -20.27M -184.92% | -13.16M -164.80% | -48.24M -522.53% | -20.55M -729.71% | -26.91M -32.78% | -29.96M -127.74% | -63.51M -31.65% | -62.91M -206.11% | 44.37M +264.85% | -72.08M -140.55% | -85.94M -35.32% | -41.93M +33.35% | 47.60M +7.29% | -104.20M -44.57% | -109.83M -27.80% | -133.41M -218.15% | -126.84M -366.45% | -173.87M -66.85% | -157.41M -43.32% | -173.70M -30.20% | 368.12M +390.23% | -177.69M -2.19% | -14.54M +90.76% | 31.07M +117.89% | 206.96M -- |
Basic EPS | -0.35 +31.37% | -0.32 -18.52% | -0.32 -- | -0.17 +46.88% | -0.08 +77.14% | -0.07 +78.13% | -0.14 +56.25% | -0.18 -5.88% | -0.18 -125.00% | -0.18 -157.14% | -0.12 +14.29% | 0.13 +172.22% | 0.25 +238.89% | 0.21 +216.67% | 0.12 +200.00% | -0.03 -123.08% | -0.2 -180.00% | -0.13 -161.90% | -0.47 -491.67% | -0.2 -566.67% | -0.26 -30.00% | -0.29 -123.08% | -0.61 -29.79% | -0.6 -200.00% | 0.42 +261.54% | -0.68 -134.48% | -0.81 -32.79% | -0.39 +35.00% | 0.46 +9.52% | -0.96 -41.18% | -1.02 -25.93% | -1.24 -217.95% | -1.02 -321.74% | -1.38 -43.75% | -1.37 -34.31% | -1.39 -12.10% | 2.78 +372.55% | -1.26 +8.70% | -0.17 +87.59% | 0.22 +115.83% | 1.57 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.96 -- | -- -- | -1.24 -- | -1.02 -- | -1.38 -43.75% | -- -- | -1.39 -12.10% | 2.78 +372.55% | -1.26 +8.70% | -- -- | 0.22 +115.83% | -- -- |
Diluted EPS | -- -- | -- -- | -- -- | -- -- | -- -- | -0.07 -- | -- -- | -0.18 -- | -0.18 -- | -0.18 -157.14% | -- -- | 0.13 +172.22% | 0.24 +233.33% | 0.21 +216.67% | -- -- | -0.03 -123.08% | -0.2 -183.33% | -0.13 -161.90% | -- -- | -0.2 -566.67% | -0.26 -30.00% | -0.29 -123.08% | -- -- | -0.6 -200.00% | 0.41 +257.69% | -0.68 -134.48% | -- -- | -0.39 +35.00% | 0.45 +9.76% | -0.96 -41.18% | -- -- | -1.24 -217.95% | -1.02 -326.67% | -1.38 -43.75% | -- -- | -1.39 -12.10% | 2.75 +369.61% | -1.26 +8.70% | -- -- | 0.22 +115.83% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.96 -- | -- -- | -1.24 -- | -1.02 -- | -1.38 -43.75% | -- -- | -1.39 -12.10% | 2.75 +369.61% | -1.26 +8.70% | -- -- | 0.22 +115.83% | -- -- |
You can ask Aime
What is the market's earnings forecast for Arrowhead Pharmaceuticals next quarter?What guidance did Arrowhead Pharmaceuticals's management provide for the next earnings period?What does Arrowhead Pharmaceuticals do and what are its main business segments?What is Arrowhead Pharmaceuticals's latest dividend and current dividend yield?Did Arrowhead Pharmaceuticals beat or miss consensus estimates last quarter?What were the key takeaways from Arrowhead Pharmaceuticals’s earnings call?What factors drove the changes in Arrowhead Pharmaceuticals's revenue and profit?What were the key takeaways from Arrowhead Pharmaceuticals's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
